Differential effects of a multidomain intervention on cognitive decline in older adults with type 2 diabetes according to white matter hyperintensity status: A secondary analysis of the J-MIND-Diabetes.

IF 5.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Taiki Sugimoto, Takuya Omura, Atsushi Araki, Chie Haneda, Keiko Honda, Minoru Kishi, Toshimasa Takahashi, Kenji Toyoshima, Suguru Tsuume, Kazuaki Uchida, Nanae Matsumoto, Hisashi Noma, Kosuke Fujita, Ayaka Onoyama, Yoko Yokoyama, Yujiro Kuroda, Paul K Crane, Takashi Sakurai
{"title":"Differential effects of a multidomain intervention on cognitive decline in older adults with type 2 diabetes according to white matter hyperintensity status: A secondary analysis of the J-MIND-Diabetes.","authors":"Taiki Sugimoto, Takuya Omura, Atsushi Araki, Chie Haneda, Keiko Honda, Minoru Kishi, Toshimasa Takahashi, Kenji Toyoshima, Suguru Tsuume, Kazuaki Uchida, Nanae Matsumoto, Hisashi Noma, Kosuke Fujita, Ayaka Onoyama, Yoko Yokoyama, Yujiro Kuroda, Paul K Crane, Takashi Sakurai","doi":"10.1111/dom.16605","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>White matter hyperintensities (WMHs) are commonly observed in older adults with type 2 diabetes. The current study aimed to investigate whether WMH modifies the effects of multidomain intervention in preventing cognitive decline among older adults with type 2 diabetes and mild cognitive impairment.</p><p><strong>Materials and methods: </strong>This secondary analysis of the Japan-Multidomain Intervention Trial for Prevention of Dementia in Older Adults with Diabetes included 154 participants aged 70-85 years who presented with type 2 diabetes and mild cognitive impairment. They were randomized into the intervention (vascular risk management, exercise, nutritional counselling and promotion of social activities) and control (provision of health-related information) groups. The primary outcome was a change in average Z-scores from all of the neuropsychological tests combined, and secondary outcomes were domain-specific composite scores (memory, executive function and processing speed) from baseline to 18 months. The presence of WMH was assessed using the Fazekas scale. The associations between the intervention and baseline WMH were evaluated using a mixed-effects model for repeated measures.</p><p><strong>Results: </strong>Among 90 participants included in the analyses, 34 had moderate to severe WMH. At the 18-month follow-up, a significant intervention-WMH interaction (p = 0.017) was found for the primary outcome. The intervention effect was significant in individuals with WMH (Z-score difference: +0.335, 95% confidence interval [CI]: +0.045 to +0.624), but not in individuals without WMH (Z-score difference: -0.121, 95% CI: -0.353 to +0.110).</p><p><strong>Conclusions: </strong>Older adults with type 2 diabetes and WMH may benefit from multidomain interventions. Further studies should be performed to validate this finding.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":""},"PeriodicalIF":5.4000,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dom.16605","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: White matter hyperintensities (WMHs) are commonly observed in older adults with type 2 diabetes. The current study aimed to investigate whether WMH modifies the effects of multidomain intervention in preventing cognitive decline among older adults with type 2 diabetes and mild cognitive impairment.

Materials and methods: This secondary analysis of the Japan-Multidomain Intervention Trial for Prevention of Dementia in Older Adults with Diabetes included 154 participants aged 70-85 years who presented with type 2 diabetes and mild cognitive impairment. They were randomized into the intervention (vascular risk management, exercise, nutritional counselling and promotion of social activities) and control (provision of health-related information) groups. The primary outcome was a change in average Z-scores from all of the neuropsychological tests combined, and secondary outcomes were domain-specific composite scores (memory, executive function and processing speed) from baseline to 18 months. The presence of WMH was assessed using the Fazekas scale. The associations between the intervention and baseline WMH were evaluated using a mixed-effects model for repeated measures.

Results: Among 90 participants included in the analyses, 34 had moderate to severe WMH. At the 18-month follow-up, a significant intervention-WMH interaction (p = 0.017) was found for the primary outcome. The intervention effect was significant in individuals with WMH (Z-score difference: +0.335, 95% confidence interval [CI]: +0.045 to +0.624), but not in individuals without WMH (Z-score difference: -0.121, 95% CI: -0.353 to +0.110).

Conclusions: Older adults with type 2 diabetes and WMH may benefit from multidomain interventions. Further studies should be performed to validate this finding.

根据白质高强度状态,多领域干预对老年2型糖尿病患者认知能力下降的不同影响:J-MIND-Diabetes的二次分析
目的:白质高强度(WMHs)常见于老年2型糖尿病患者。目前的研究旨在调查WMH是否改变了多域干预在预防老年2型糖尿病和轻度认知障碍患者认知能力下降中的作用。材料和方法:对日本糖尿病老年痴呆预防多领域干预试验的二次分析纳入了154名年龄在70-85岁之间的2型糖尿病和轻度认知障碍患者。他们被随机分为干预组(血管风险管理、锻炼、营养咨询和促进社会活动)和控制组(提供健康相关信息)。主要结果是所有神经心理测试的平均z得分的变化,次要结果是特定领域的综合得分(记忆、执行功能和处理速度)从基线到18个月。采用Fazekas量表评估WMH的存在。使用重复测量的混合效应模型评估干预与基线WMH之间的关联。结果:在纳入分析的90名参与者中,34名患有中度至重度WMH。在18个月的随访中,在主要结局中发现了显著的干预- wmh相互作用(p = 0.017)。干预效果在WMH患者中显著(Z-score差异:+0.335,95%可信区间[CI]: +0.045 ~ +0.624),而在无WMH患者中不显著(Z-score差异:-0.121,95% CI: -0.353 ~ +0.110)。结论:老年2型糖尿病和WMH患者可能受益于多领域干预。应该进行进一步的研究来验证这一发现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism 医学-内分泌学与代谢
CiteScore
10.90
自引率
6.90%
发文量
319
审稿时长
3-8 weeks
期刊介绍: Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信